Matches in Wikidata for { <http://www.wikidata.org/entity/Q102073605> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q102073605 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 16ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q102073605 description "artículu científicu espublizáu en payares de 2020" @default.
- Q102073605 description "scientific article published on 16 November 2020" @default.
- Q102073605 description "wetenschappelijk artikel" @default.
- Q102073605 description "наукова стаття, опублікована 16 листопада 2020" @default.
- Q102073605 name "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 name "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 name "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 type Item @default.
- Q102073605 label "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 label "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 label "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 prefLabel "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 prefLabel "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 prefLabel "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 P1433 Q102073605-2ADA63AE-BD16-4289-A376-1C3465A54AEA @default.
- Q102073605 P1476 Q102073605-4A691EA9-9A65-4C0D-9B55-1DCD3C081139 @default.
- Q102073605 P2093 Q102073605-0733EC15-0349-4CA6-BE30-3C4F04005B7D @default.
- Q102073605 P2093 Q102073605-1DB3CE5E-B7C9-41B2-A2A7-D3BE8B0BED1A @default.
- Q102073605 P2093 Q102073605-60517187-061F-4027-AC7A-26D92299853B @default.
- Q102073605 P2093 Q102073605-73A014EE-275E-4362-AABC-3B92AD8A5BBE @default.
- Q102073605 P2093 Q102073605-95D116DF-2D9E-4F31-908F-FF2FA10DBD34 @default.
- Q102073605 P2093 Q102073605-A6173D78-400E-4DA7-AD60-9523E6FFF7C3 @default.
- Q102073605 P2093 Q102073605-C7B4DF4E-2B02-421B-9D40-01E0C75867CE @default.
- Q102073605 P304 Q102073605-E833E531-219B-4896-9D5E-D83DA265690F @default.
- Q102073605 P31 Q102073605-6B516555-253D-4E43-AF48-3D096DF3A6E7 @default.
- Q102073605 P356 Q102073605-0EDB452C-2ECD-4459-93AE-0AF9FD79491A @default.
- Q102073605 P433 Q102073605-06D17877-9717-4691-B882-C18FD02C9FBF @default.
- Q102073605 P478 Q102073605-3B1276E2-1639-46FA-A665-3DD5F062C2CF @default.
- Q102073605 P50 Q102073605-194A7B7D-31B3-4159-A0DD-2E10C5C5D3E3 @default.
- Q102073605 P577 Q102073605-86785078-EBD0-4ACD-AD40-1E472959335D @default.
- Q102073605 P698 Q102073605-A8723F27-6B24-43B1-AD64-B5A2FCE5AE70 @default.
- Q102073605 P932 Q102073605-D382D49C-7FE7-460B-933D-B435C6A97976 @default.
- Q102073605 P356 S12885-020-07505-W @default.
- Q102073605 P698 33198673 @default.
- Q102073605 P1433 Q326300 @default.
- Q102073605 P1476 "Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy" @default.
- Q102073605 P2093 "Ho Yong Park" @default.
- Q102073605 P2093 "In Hee Lee" @default.
- Q102073605 P2093 "Jeeyeon Lee" @default.
- Q102073605 P2093 "Jin Hyang Jung" @default.
- Q102073605 P2093 "Sang-Woo Lee" @default.
- Q102073605 P2093 "Shin Young Jeong" @default.
- Q102073605 P2093 "Soo Jung Lee" @default.
- Q102073605 P304 "1106" @default.
- Q102073605 P31 Q13442814 @default.
- Q102073605 P356 "10.1186/S12885-020-07505-W" @default.
- Q102073605 P433 "1" @default.
- Q102073605 P478 "20" @default.
- Q102073605 P50 Q92384025 @default.
- Q102073605 P577 "2020-11-16T00:00:00Z" @default.
- Q102073605 P698 "33198673" @default.
- Q102073605 P932 "7667770" @default.